Stonehaven
Stonehaven, founded in 2001 and headquartered in New York City, is a global FinTech platform focused on private capital markets. It serves a diverse community of investment bankers and placement agents, facilitating transactions across various asset classes, including real estate, private equity, venture capital, private credit, hedge funds, and mergers and acquisitions. The firm engages with clients across multiple industries, such as software, healthcare, retail, media, agriculture, insurance, capital markets, manufacturing, cannabis, cybersecurity, and health technology. Stonehaven's commitment to innovation and technology enhances the efficiency of capital raising processes for its clients.
Top Regions
Top Stages
1 past transactions
Response Pharmaceuticals
Series A in 2022
Response Pharmaceuticals is a biotechnology and pharmaceutical company focused on developing innovative treatments for the metabolic side effects associated with antipsychotic medications. The company is working on an iMTP inhibitor aimed at addressing weight management and metabolic diseases, thereby facilitating quicker recovery for patients dealing with mental health issues while also combating weight gain and metabolic dysregulation. Through its research and development efforts, Response Pharmaceuticals seeks to improve the quality of life for individuals affected by these conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.